Dr. Arcasoy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke University Medical Center
Box 3912 Dumc
Durham, NC 27710Phone+1 919-668-6309Fax+1 919-681-6160
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1998- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1988 - 1992
Ege Univ- Fac MedClass of 1987
Certifications & Licensure
NC State Medical License 1999 - 2025
CT State Medical License 1990 - 2000
NY State Medical License 1991 - 1994
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- Correlative Biomarker Study in Patients With Myeloproliferative Disorders Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms.Sandy El Bitar, Murat O Arcasoy
Clinical Advances in Hematology & Oncology. 2024-03-01 - 2 citationsUpfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble
Bone Marrow Transplantation. 2024-02-01 - Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble
Bone Marrow Transplantation. 2024-02-01
Grant Support
- Erythropoietin Receptors In Breast CancerNational Cancer Institute2004–2008
- Role Of Erythropoietin Receptor Signaling In HeartNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Erythropoietin Receptor Regulation Of ErythropoiesisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Erythropoietin Receptor Regulation Of ErythropoiesisNational Institute Of Diabetes And Digestive And Kidney Diseases1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
